Sudden cardiac death in China

Area of Science:

• Cardiology
• Public Health
• Epidemiology

Background:

• Sudden cardiac death (SCD) represents a significant public health concern in China, with preliminary data indicating a concerning mortality rate.
• Coronary artery disease is the leading cause of SCD, but endemic cardiomyopathies and hereditary heart conditions also contribute significantly within the Chinese population.

Purpose of the Study:

• To summarize the current landscape of sudden cardiac death (SCD) in China.
• To highlight the primary causes, existing treatment strategies, and emerging prevention initiatives for SCD in the region.

Main Methods:

• Analysis of preliminary epidemiological data on SCD incidence and mortality in China.
• Review of current pharmacological treatments, community resuscitation efforts, and advanced therapies like implantable cardioverter defibrillators and catheter ablation.
• Inclusion of information on a newly initiated national SCD prevention project.

Main Results:

• Preliminary data indicate an SCD rate of 41.8 per 100,000 population in China, resulting in over 544,000 deaths annually.
• Coronary artery disease accounts for approximately 70% of SCD cases.
• Treatment options, including community resuscitation and implantable cardioverter defibrillator therapy, face socioeconomic limitations, while catheter ablation for ventricular arrhythmias is increasingly utilized.

Conclusions:

• Sudden cardiac death (SCD) is a critical issue in China, driven by coronary artery disease and specific endemic heart conditions.
• Current treatment strategies are constrained by socioeconomic factors, necessitating innovative approaches.
• A national initiative has been launched to bolster SCD prevention efforts across China.